Poteligeo savings card: $0 a prescription with commercial insurance

Poteligeo is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Poteligeo is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand namePoteligeo

Authorized genericmogamulizumab-kpkc

Regular genericmogamulizumab-kpkc

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Poteligeo?

The original

–

Brand nameThe maker’s card

Kyowa Kirin Cares Copay Assistance Program

Savings card from Kyowa Kirin

No insuranceNeeds insuranceNo cash price listed.

Insurance $0 a prescription

The card takes up to $10,000 a year off your co-pay.

Or call 1-833-552-2737.

In the maker’s words

“Under the program, most commercially insured patients pay $0 out-of-pocket costs for their POTELIGEO prescription.”

From the maker’s offer on poteligeohcp.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Poteligeo itself, from the same company, sold without the brand name, and usually for less. For now Poteligeo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Poteligeo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

POTELIGEO is a CC chemokine receptor type 4 (CCR4)-directed monoclonal antibody indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy.

Source: the FDA label for Poteligeo (Kyowa Kirin, Inc.), March 2, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/poteligeo/